Prostate Cancer Pathology: Recent Updates and Controversies

Prostate cancer is common, and recent efforts in clinical management have focused on identifying patients who could be candidates from less aggressive management or who could benefit from more aggressive therapy. As prostate cancer histology, especially Gleason score, plays a critical role in predic...

Full description

Saved in:
Bibliographic Details
Published in:Missouri medicine 2018-03, Vol.115 (2), p.151-155
Main Author: Sehn, Jennifer K
Format: Article
Language:English
Subjects:
Biopsy
Humans
Male
Neoplasm Grading - trends
Prognosis
Prostate - pathology
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - pathology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 155
container_issue 2
container_start_page 151
container_title Missouri medicine
container_volume 115
creator Sehn, Jennifer K
description Prostate cancer is common, and recent efforts in clinical management have focused on identifying patients who could be candidates from less aggressive management or who could benefit from more aggressive therapy. As prostate cancer histology, especially Gleason score, plays a critical role in predicting patient outcomes, attempts have been made to refine histologic classification and reporting in prostate cancer to facilitate patient risk stratification. This review discusses recent updates in prostate cancer grading and reporting.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6139855</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2111151536</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1115-ba01191466b64c0a8cc3d4e2989d0a88d0430fcee67042c6df026a318bd882853</originalsourceid><addsrcrecordid>eNpVkN1LwzAUxfOguDn9F6SPvhTy0WapgiDFLxg4xD2HNLndKm1Sk3Sw_94Wp-jT5XIuv3POPUFzjClPOad4hs5D-MCYFYLRMzRjmFKxxGKObtfehagiJKWyGnyyVnHnWrc93CRvoMHGZNObUQ-JsiYpnY3e7cGHBsIFOq1VG-DyOBdo8_jwXj6nq9enl_J-lfaEkDytFCakIBnnFc80VkJrZjKghSjMuAmDM4ZrDcCXOKOam3qMrRgRlRGCipwt0N03tx-qDswUyqtW9r7plD9Ipxr5X7HNTm7dXnIyFs4nwPUR4N3nACHKrgka2lZZcEOQlExBSc74eHr11-vX5Odj7Av54maa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2111151536</pqid></control><display><type>article</type><title>Prostate Cancer Pathology: Recent Updates and Controversies</title><source>PubMed Central Free</source><creator>Sehn, Jennifer K</creator><creatorcontrib>Sehn, Jennifer K</creatorcontrib><description>Prostate cancer is common, and recent efforts in clinical management have focused on identifying patients who could be candidates from less aggressive management or who could benefit from more aggressive therapy. As prostate cancer histology, especially Gleason score, plays a critical role in predicting patient outcomes, attempts have been made to refine histologic classification and reporting in prostate cancer to facilitate patient risk stratification. This review discusses recent updates in prostate cancer grading and reporting.</description><identifier>ISSN: 0026-6620</identifier><identifier>PMID: 30228708</identifier><language>eng</language><publisher>United States: Journal of the Missouri State Medical Association</publisher><subject>Biopsy ; Humans ; Male ; Neoplasm Grading - trends ; Prognosis ; Prostate - pathology ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - pathology</subject><ispartof>Missouri medicine, 2018-03, Vol.115 (2), p.151-155</ispartof><rights>Copyright 2018 by the Missouri State Medical Association 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139855/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139855/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30228708$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sehn, Jennifer K</creatorcontrib><title>Prostate Cancer Pathology: Recent Updates and Controversies</title><title>Missouri medicine</title><addtitle>Mo Med</addtitle><description>Prostate cancer is common, and recent efforts in clinical management have focused on identifying patients who could be candidates from less aggressive management or who could benefit from more aggressive therapy. As prostate cancer histology, especially Gleason score, plays a critical role in predicting patient outcomes, attempts have been made to refine histologic classification and reporting in prostate cancer to facilitate patient risk stratification. This review discusses recent updates in prostate cancer grading and reporting.</description><subject>Biopsy</subject><subject>Humans</subject><subject>Male</subject><subject>Neoplasm Grading - trends</subject><subject>Prognosis</subject><subject>Prostate - pathology</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - pathology</subject><issn>0026-6620</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVkN1LwzAUxfOguDn9F6SPvhTy0WapgiDFLxg4xD2HNLndKm1Sk3Sw_94Wp-jT5XIuv3POPUFzjClPOad4hs5D-MCYFYLRMzRjmFKxxGKObtfehagiJKWyGnyyVnHnWrc93CRvoMHGZNObUQ-JsiYpnY3e7cGHBsIFOq1VG-DyOBdo8_jwXj6nq9enl_J-lfaEkDytFCakIBnnFc80VkJrZjKghSjMuAmDM4ZrDcCXOKOam3qMrRgRlRGCipwt0N03tx-qDswUyqtW9r7plD9Ipxr5X7HNTm7dXnIyFs4nwPUR4N3nACHKrgka2lZZcEOQlExBSc74eHr11-vX5Odj7Av54maa</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Sehn, Jennifer K</creator><general>Journal of the Missouri State Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201803</creationdate><title>Prostate Cancer Pathology: Recent Updates and Controversies</title><author>Sehn, Jennifer K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1115-ba01191466b64c0a8cc3d4e2989d0a88d0430fcee67042c6df026a318bd882853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Biopsy</topic><topic>Humans</topic><topic>Male</topic><topic>Neoplasm Grading - trends</topic><topic>Prognosis</topic><topic>Prostate - pathology</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sehn, Jennifer K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Missouri medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sehn, Jennifer K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prostate Cancer Pathology: Recent Updates and Controversies</atitle><jtitle>Missouri medicine</jtitle><addtitle>Mo Med</addtitle><date>2018-03</date><risdate>2018</risdate><volume>115</volume><issue>2</issue><spage>151</spage><epage>155</epage><pages>151-155</pages><issn>0026-6620</issn><abstract>Prostate cancer is common, and recent efforts in clinical management have focused on identifying patients who could be candidates from less aggressive management or who could benefit from more aggressive therapy. As prostate cancer histology, especially Gleason score, plays a critical role in predicting patient outcomes, attempts have been made to refine histologic classification and reporting in prostate cancer to facilitate patient risk stratification. This review discusses recent updates in prostate cancer grading and reporting.</abstract><cop>United States</cop><pub>Journal of the Missouri State Medical Association</pub><pmid>30228708</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-6620
ispartof Missouri medicine, 2018-03, Vol.115 (2), p.151-155
issn 0026-6620
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6139855
source PubMed Central Free
subjects Biopsy
Humans
Male
Neoplasm Grading - trends
Prognosis
Prostate - pathology
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - pathology
title Prostate Cancer Pathology: Recent Updates and Controversies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A25%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prostate%20Cancer%20Pathology:%20Recent%20Updates%20and%20Controversies&rft.jtitle=Missouri%20medicine&rft.au=Sehn,%20Jennifer%20K&rft.date=2018-03&rft.volume=115&rft.issue=2&rft.spage=151&rft.epage=155&rft.pages=151-155&rft.issn=0026-6620&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2111151536%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p1115-ba01191466b64c0a8cc3d4e2989d0a88d0430fcee67042c6df026a318bd882853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2111151536&rft_id=info:pmid/30228708&rfr_iscdi=true